Report cover image

Desmopressin Market by Form (Injectable Solution, Nasal Spray, Tablet), Sales Channel (Offline, Online), End-Users - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 194 Pages
SKU # IRE18442687

Description

Desmopressin Market by Form (Injectable Solution, Nasal Spray, Tablet), Sales Channel (Offline, Online), End-Users - Global Forecast 2024-2030


The Desmopressin Market size was estimated at USD 1.25 billion in 2023 and expected to reach USD 1.30 billion in 2024, at a CAGR 6.68% to reach USD 1.97 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Desmopressin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Desmopressin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Desmopressin Market, highlighting leading vendors and their innovative profiles. These include AA Pharma Inc., Amring Pharmaceuticals Inc., Antares Pharma, Inc. by Halozyme, Inc., Apotex Inc., Avadel Pharmaceuticals PLC, Bachem AG, BluePoint Laboratories, CSC Pharmaceuticals International, Dr. Reddy's Laboratories Ltd., Enomark, Ferring Pharmaceuticals, Glenmark Pharmaceuticals Limited, Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey, KVR Pharmaceuticals, Manus Aktteva Biopharma LLP, Midas Pharma GmbH, NorthStar Rx LLC, Pfizer Inc., Ralington Pharma LLP, Saintroy Lifescience, Sanofi S.A., Sava Healthcare Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and VIVAN Life Sciences Pvt. Limited.

Market Segmentation & Coverage

This research report categorizes the Desmopressin Market to forecast the revenues and analyze trends in each of the following sub-markets:

Form
Injectable Solution

Nasal Spray

Tablet
Sales Channel
Offline

Online
End-Users
Homecare

Hospitals

Specialty Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Desmopressin Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Desmopressin Market?
3. What are the technology trends and regulatory frameworks in the Desmopressin Market?
4. What is the market share of the leading vendors in the Desmopressin Market?
5. Which modes and strategic moves are suitable for entering the Desmopressin Market?PDF E-mail From Publisher (2-5)Users License

Table of Contents

194 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Desmopressin Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising occurrence of diabetes insipidus in patients worldwide
5.1.1.2. Government initiatives and programs supporting diabetes awareness & treatment
5.1.2. Restraints
5.1.2.1. Adverse effects associated with the desmopressin
5.1.3. Opportunities
5.1.3.1. Ongoing research & development activities for new formulations
5.1.3.2. Increasing in regulatory approvals for desmopressin
5.1.4. Challenges
5.1.4.1. Availability of alternative medicines
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Desmopressin Market, by Form
6.1. Introduction
6.2. Injectable Solution
6.3. Nasal Spray
6.4. Tablet
7. Desmopressin Market, by Sales Channel
7.1. Introduction
7.2. Offline
7.3. Online
8. Desmopressin Market, by End-Users
8.1. Introduction
8.2. Homecare
8.3. Hospitals
8.4. Specialty Clinics
9. Americas Desmopressin Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Desmopressin Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Desmopressin Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AA Pharma Inc.
13.1.2. Amring Pharmaceuticals Inc.
13.1.3. Antares Pharma, Inc. by Halozyme, Inc.
13.1.4. Apotex Inc.
13.1.5. Avadel Pharmaceuticals PLC
13.1.6. Bachem AG
13.1.7. BluePoint Laboratories
13.1.8. CSC Pharmaceuticals International
13.1.9. Dr. Reddy's Laboratories Ltd.
13.1.10. Enomark
13.1.11. Ferring Pharmaceuticals
13.1.12. Glenmark Pharmaceuticals Limited
13.1.13. Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey
13.1.14. KVR Pharmaceuticals
13.1.15. Manus Aktteva Biopharma LLP
13.1.16. Midas Pharma GmbH
13.1.17. NorthStar Rx LLC
13.1.18. Pfizer Inc.
13.1.19. Ralington Pharma LLP
13.1.20. Saintroy Lifescience
13.1.21. Sanofi S.A.
13.1.22. Sava Healthcare Limited
13.1.23. Sun Pharmaceutical Industries Limited
13.1.24. Teva Pharmaceutical Industries Ltd.
13.1.25. VIVAN Life Sciences Pvt. Limited
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. DESMOPRESSIN MARKET RESEARCH PROCESS
FIGURE 2. DESMOPRESSIN MARKET SIZE, 2023 VS 2030
FIGURE 3. DESMOPRESSIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DESMOPRESSIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DESMOPRESSIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DESMOPRESSIN MARKET DYNAMICS
FIGURE 7. DESMOPRESSIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 8. DESMOPRESSIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
FIGURE 10. DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. DESMOPRESSIN MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 12. DESMOPRESSIN MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. DESMOPRESSIN MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. DESMOPRESSIN MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us